West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)
Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%
West Pharmaceutical Services price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
West Pharmaceutical Services's price to book ratio was 9.7× on Nov 11, 2026, against 6.5× a year earlier. Over the last 5 years it ranged from 5.4× to 15.8×, with a median of 8.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.7× | +3.2 |
| 2025 | Dec 31, 2025 | 6.5× | −2.1 |
| 2024 | Dec 31, 2024 | 8.6× | −0.5 |
| 2023 | Dec 29, 2023 | 9.1× | +2.0 |
| 2022 | Dec 30, 2022 | 7.0× | −8.7 |
| 2021 | Dec 31, 2021 | 15.8× | +3.6 |
| 2020 | Dec 31, 2020 | 12.2× | +4.7 |
| 2019 | Dec 31, 2019 | 7.5× | +2.4 |
| 2018 | Apr 30, 2018 | 5.1× | – |
See a number that looks wrong?